RVPH icon

Reviva Pharmaceuticals

12 hedge funds and large institutions have $12.8M invested in Reviva Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Holders
12
Holders Change
+4
Holders Change %
+50%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
1
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TCM
1
Tang Capital Management
California
$5.83M 1,200,000 +1,200,000 New
AC
2
Armistice Capital
New York
$3.47M 714,700 +714,700 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.57M 529,464 +529,464 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$329K 67,724 +67,724 New
ECM
5
EMC Capital Management
Texas
$257K 75,835
BlackRock
6
BlackRock
New York
$89K 18,318 +18,318 New
TRCT
7
Tower Research Capital (TRC)
New York
$61K 12,484 +10,408 +501%
Renaissance Technologies
8
Renaissance Technologies
New York
$55K 11,250 +11,250 New
Northern Trust
9
Northern Trust
Illinois
$51K 10,584 +10,584 New
DC
10
Davenport & Co
Virginia
$49K 10,000 -5,000 -33%
UBS Group
11
UBS Group
Switzerland
$10K 2,033 +2,033 New
SM
12
Sabby Management
Florida
-418,437 Closed
Citadel Advisors
13
Citadel Advisors
Florida
-36,652 Closed
Millennium Management
14
Millennium Management
New York
-35,310 Closed
WAM
15
Wolverine Asset Management
Illinois
-3,078 Closed
Wells Fargo
16
Wells Fargo
California
$0 34
CFGS
17
Concourse Financial Group Securities
Alabama